![Stephen Pakola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Pakola
Technik-/Wissenschafts-/F&E-Leiter bei
REGENXBIO INC.
Vermögen: 2 Mio $ am 31.07.2026
Profil
Stephen Pakola is Chief Medical Officer & EVP at REGENXBIO, Inc. since 2024 and Chief Medical Officer at Aerpio Therapeutics LLC since 2015.
Former roles include Chief Medical Officer at Oxurion NV, Chief Medical Officer at Amakem NV from 2012 to 2015, Chief Medical Officer at Thrombogenics, Inc. from 2000 to 2015, Chief Medical Officer at Aerpio Pharmaceuticals, Inc. from 2015 to 2019, and Associate Director at Boehringer Ingelheim Pharmaceuticals, Inc. from 1998 to 2000.
Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
REGENXBIO, INC. 0.31% | 01.08.2026 | 205’541 ( 0.31% ) | 2 Mio $ | 31.07.2026 |
Aktive Positionen von Stephen Pakola
| Unternehmen | Position | Beginn |
|---|---|---|
| REGENXBIO INC. | Technik-/Wissenschafts-/F&E-Leiter | 17.04.2019 |
Aerpio Therapeutics LLC
 Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Technik-/Wissenschafts-/F&E-Leiter | 06.10.2015 |
Ehemalige bekannte Positionen von Stephen Pakola
| Unternehmen | Position | Ende |
|---|---|---|
| AERPIO PHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | 17.04.2019 |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2015 |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2015 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01.01.2000 |
| OXURION NV | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Stephen Pakola
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Aerpio Therapeutics LLC
Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Oxurion NV
 Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
